✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Orchid Pharma Ltd.

ORCHPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,552 Cr.
P/E
41.68

Orchid Pharma Ltd.

  • Orchid Pharma
  • Gufic Biosciences
  • Unichem Lab

FAQs on Orchid Pharma Ltd. Shareprice

Orchid Pharma has given better returns compared to its competitors.
Orchid Pharma has grown at ~57.83% over the last 8yrs while peers have grown at a median rate of 8.69%

Orchid Pharma is not expensive.
Latest PE of Orchid Pharma is 42.28, while 3 year average PE is 47.99.
Also latest EV/EBITDA of Orchid Pharma is 36.39 while 3yr average is 42.75.

View FAQ's On Business

Growth Table

  • Orchid Pharma Ltd.
  • Gufic Biosciences
  • Unichem Lab

Balance Sheet

  • Orchid Pharma Ltd.
  • Gufic Biosciences
  • Unichem Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Orchid Pharma Ltd.
  • Gufic Biosciences
  • Unichem Lab

Cash Flow

  • Orchid Pharma Ltd.
  • Gufic Biosciences
  • Unichem Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Orchid Pharma Ltd.
  • Gufic Biosciences
  • Unichem Lab

Quarterly Results

  • Orchid Pharma Ltd.
  • Gufic Biosciences
  • Unichem Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Orchid Pharma Ltd. Financials

Balance sheet of Orchid Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Orchid Pharma is increasing.
Latest net debt of Orchid Pharma is -₹184.93 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹398.61 Crs.

The profit is oscillating.
The profit of Orchid Pharma is ₹81.2 Crs for TTM, ₹99.66 Crs for Mar 2025 and ₹92.17 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Orchid Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech